Cover Image
市場調查報告書

急性肺損傷:全球臨床實驗趨勢

Lung Injury Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 146185
出版日期 內容資訊 英文 106 Pages
訂單完成後即時交付
價格
Back to Top
急性肺損傷:全球臨床實驗趨勢 Lung Injury Global Clinical Trials Review, H2, 2017
出版日期: 2017年11月30日 內容資訊: 英文 106 Pages
簡介

本報告依各地區,各國,各期提供急性肺損傷相關臨床實驗趨勢分析,並彙整參與企業,機關,大學,醫院趨勢,現在正在開發的藥物概要等資料。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:呼吸系統疾病治療藥臨床實驗上急性肺損傷的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:呼吸系統疾病治療藥臨床實驗上急性肺損傷的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

急性肺損傷治療藥臨床實驗參與的主要企業

有潛力的藥劑

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4728CTIDB

GlobalData's clinical trial report, "Lung Injury Global Clinical Trials Review, H2, 2017" provides an overview of Lung Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Lung Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Lung Injury to Respiratory Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Lung Injury to Respiratory Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Lung Injury Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29

Appendix 104

  • Abbreviations 104
  • Definitions 104
  • Research Methodology 105
  • Secondary Research 105
  • About GlobalData 106
  • Contact Us 106
  • Source 106

List of Tables

List of Tables

  • Lung Injury Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Lung Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Lung Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Lung Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
  • Lung Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Lung Injury Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Lung Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
  • Lung Injury Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Lung Injury to Respiratory Clinical Trials, G7 Countries (%), 2017* 14
  • Lung Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Lung Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Lung Injury to Respiratory Clinical Trials, E7 Countries (%), 2017* 17
  • Lung Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Lung Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Lung Injury Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Lung Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Lung Injury Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Lung Injury Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Lung Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Lung Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Lung Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Lung Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Lung Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
Back to Top